Sayuri Horikawa
Shinjuku, 1698555, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
High-finesse nanofiber Fabry-Pérot resonator in a portable storage container.
Journal: The Review of scientific instruments
Published: March 18, 2024
Antibody to CD137 Activated by Extracellular Adenosine Triphosphate Is Tumor Selective and Broadly Effective In Vivo without Systemic Immune Activation.
Journal: Cancer discovery
Published: March 17, 2020
Expression of mutant Asxl1 perturbs hematopoiesis and promotes susceptibility to leukemic transformation.
Journal: The Journal of experimental medicine
Published: June 27, 2017
Novel working hypothesis for pathogenesis of hematological malignancies: combination of mutations-induced cellular phenotypes determines the disease (cMIP-DD).
Journal: Journal of biochemistry
Published: September 27, 2015
The molecular basis of myeloid malignancies.
Journal: Proceedings of the Japan Academy. Series B, Physical and biological sciences
Published: December 16, 2014
Human NAT10 is an ATP-dependent RNA acetyltransferase responsible for N4-acetylcytidine formation in 18 S ribosomal RNA (rRNA).
Journal: The Journal of biological chemistry
Published: November 21, 2014
Molecular basis of hematological malignancies
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: October 10, 2014
SETBP1 mutations drive leukemic transformation in ASXL1-mutated MDS.
Journal: Leukemia
Published: August 19, 2014
A C-terminal mutant of CCAAT-enhancer-binding protein α (C/EBPα-Cm) downregulates Csf1r, a potent accelerator in the progression of acute myeloid leukemia with C/EBPα-Cm.
Journal: Experimental hematology
Published: July 17, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026